The Board of Directors of Aurinia Pharmaceuticals Inc. has authorized a buyback plan on February 15, 2024.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.985 USD | +1.53% | -1.39% | -44.61% |
Mar. 20 | ILJIN SNT Delivers a Letter to Aurinia Pharmaceuticals | CI |
Mar. 07 | Aurinia Pharmaceuticals Insider Sold Shares Worth $711,094, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.61% | 710M | |
-2.72% | 103B | |
+1.67% | 95.28B | |
+1.46% | 22.15B | |
-15.70% | 21.02B | |
-8.58% | 18.15B | |
-41.01% | 16.73B | |
-13.28% | 16.05B | |
+4.62% | 13.68B | |
+34.96% | 12.17B |
- Stock Market
- Equities
- AUPH Stock
- News Aurinia Pharmaceuticals Inc.
- Aurinia Pharmaceuticals Inc. authorizes a Buyback Plan.